Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Hydrocortisone
Drug ID BADD_D01086
Description Hydrocortisone, or cortisol, is a glucocorticoid secreted by the adrenal cortex.[A188387] Hydrocortisone is used to treat immune, inflammatory, and neoplastic conditions.[L10529,L10532,L10535,L10538,L7772,L7321] It was discovered in the 1930s by Edward Kendall and named Compound F, or 17-hydroxycorticosterone.[A188420] Hydrocortisone was granted FDA approval on 5 August 1952.[L10574]
Indications and Usage Otic solutions are indicated for infections of the external auditory canal caused by susceptible organisms and with inflammation.[L10529,L10532] Hydrocortisone tablets are indicated for certain endocrine, rheumatic, collagen, allergic, ophthalmic, respiratory, hematologic, neoplastic, edematous, gastrointestinal, and other conditions.[L10535] A hydrocortisone enema is indicated for ulcerative colitis,[L10538] a topical ointment with antibiotics is indicated for corticosteroid responsive dermatoses with infections,[L7772] and a topical cream with [acyclovir] is indicated to treat cold sores.[L7321] Oral granules of hydrocortisone are used as a replacement therapy for Adrenocortical Insufficiency (AI) in children under 17 years of age.[L16533]
Marketing Status approved; vet_approved
ATC Code A01AC03; A07EA02; C05AA01; D07AA02; D07XA01; H02AB09; S01BA02; S01CB03; S02BA01
DrugBank ID DB00741
KEGG ID D00088
MeSH ID D006854
PubChem ID 5754
TTD Drug ID D0KR5B
NDC Product Code 76314-004; 38779-0009; 0904-7623; 51927-0143; 55718-159; 57582-013; 10356-120; 86014-200; 11673-057; 24286-1560; 30142-369; 0113-7006; 41167-0036; 41167-0331; 41167-0338; 41520-201; 0168-0146; 45334-327; 45802-276; 49035-973; 50090-5470; 51316-227; 51326-108; 51532-4608; 51672-2010; 51672-3004; 55910-646; 59088-209; 59256-004; 59779-878; 60687-582; 61010-5800; 63629-1952; 64980-301; 65923-035; 68062-9106; 68071-2818; 68788-8302; 0472-0321; 69842-155; 72189-276; 76348-585; 76348-804; 76420-028; 79481-0319; 37946-7520; 58624-0700; 11673-399; 11822-0471; 24385-276; 30142-541; 36800-524; 0115-1700; 41163-319; 41167-0342; 41167-0344; 42213-370; 43136-203; 43749-620; 45802-004; 49348-441; 50090-0350; 50090-5999; 50382-024; 51414-106; 55621-001; 55621-018; 55910-504; 62135-552; 63187-575; 63629-8667; 63736-339; 63868-689; 65923-393; 65923-925; 67234-010; 68016-099; 68016-102; 68071-1598; 69396-017; 70403-922; 71335-1989; 71399-0180; 72162-2018; 79481-0471; 79903-091; 0574-0420; 0904-7188; 49452-3580; 66406-0285; 68981-002; 11673-353; 21130-166; 24385-274; 0096-0732; 29784-142; 41163-471; 41163-973; 41167-0021; 41415-047; 0009-0044; 43136-103; 45802-014; 45802-937; 47682-397; 51822-021; 53002-9660; 53145-430; 53943-269; 53943-984; 58232-4010; 59088-268; 61269-345; 62135-551; 62172-203; 62282-504; 62559-138; 62559-430; 63187-543; 0363-1973; 63629-2529; 63629-8666; 63941-312; 65923-494; 67510-0065; 67510-0632; 68788-9922; 69315-312; 70518-3078; 70518-3275; 0573-0552; 71335-2044; 55301-201; 0316-0186; 0316-0193; 0316-0291; 59762-0073; 59762-0075; 61010-4402; 63629-2527; 63824-851; 63941-229; 0394-0859; 68071-2897; 68726-123; 68726-504; 69396-050; 69396-118; 69473-017; 69842-192; 70288-714; 71205-034; 72189-209; 76314-003; 79903-092; 55718-160; 58624-0703; 81918-001; 11673-398; 11822-2099; 36800-939; 0115-1696; 41167-0033; 41167-0039; 41167-0105; 41167-0108; 41167-0330; 41167-0336; 41250-887; 44911-0275; 45865-630; 0178-0455; 49035-732; 50268-407; 51414-107; 51824-050; 53002-8350; 53002-9662; 53329-091; 61269-343; 62011-0095; 62011-0096; 62135-020; 0363-0670; 63015-242; 63187-567; 64380-970; 65649-501; 68062-2264; 68071-2233; 68071-2261; 68391-100; 69396-028; 69396-055; 69842-292; 70000-0495; 71516-342; 72789-228; 37946-7518; 30142-411; 0113-1369; 36800-471; 36800-981; 41167-0032; 41167-0035; 41520-319; 42543-971; 42543-972; 0168-0015; 0168-0080; 43742-1275; 43749-250; 47682-211; 51672-2013; 53943-985; 55700-321; 55910-541; 59651-415; 59762-0074; 61269-339; 63187-504; 63868-955; 68016-063; 68071-5205; 68788-8455; 69396-005; 69968-0511; 76314-002; 79481-0973; 79503-202; 0924-5633; 60722-1001; 21130-395; 24385-021; 0113-0471; 0113-0541; 0113-0973; 0115-1697; 37808-973; 41167-0335; 41250-369; 0168-0020; 44577-623; 50090-0527; 55315-182; 59779-729; 62135-186; 62742-4077; 63187-480; 63629-8668; 63629-9057; 63736-029; 64380-971; 65649-401; 67091-419; 68016-909; 68062-9103; 68788-8078; 0472-0337; 69103-4506; 69396-081; 69729-269; 71101-800; 71399-0120; 73408-933; 73408-981; 76420-110; 0009-0069; 22552-0037; 37946-6503; 51927-0144; 10107-429; 59929-107; 64025-0001; 64958-0008; 64958-0096; 66406-0050; 71216-3006; 82298-101; 11527-052; 11673-202; 11673-842; 24385-190; 30142-973; 36800-018; 36800-059; 37808-319; 37808-471; 41167-0028; 41520-033; 42543-970; 47682-398; 49035-707; 49967-108; 51316-230; 51672-3003; 52410-3050; 55315-181; 0316-0128; 62559-431
UNII WI4X0X7BPJ
Synonyms Hydrocortisone | Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)- | Cortisol | Cortef | Hydrocortisone, (11 alpha)-Isomer | Epicortisol | 11-Epicortisol | 11 Epicortisol | Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer | Cortifair | Cortril
Chemical Information
Molecular Formula C21H30O5
CAS Registry Number 50-23-7
SMILES CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Viral infection11.05.04.001---
Vision blurred06.02.06.007; 17.17.01.0100.000092%
Visual acuity reduced06.02.10.012; 17.17.01.0110.000046%
Visual impairment06.02.10.0130.000046%-
Vomiting07.01.07.0030.000489%
Weight decreased13.15.01.005--
Weight increased13.15.01.006--
Wheezing22.03.01.0090.000161%
Multiple sclerosis relapse17.16.01.0030.000069%-
Skin maceration23.03.03.016---
Poor venous access24.03.02.0170.000046%-
Hypoglycaemic seizure05.06.03.002; 14.06.03.002; 17.12.03.0150.000046%-
Peripheral swelling02.05.04.015; 08.01.03.0530.000217%-
Weight fluctuation14.03.02.002---
Oesophagitis ulcerative07.04.05.003---
General physical health deterioration08.01.03.018---
Balance disorder08.01.03.081; 17.02.02.007---
Lupus-like syndrome10.04.03.003; 15.06.02.004; 23.03.02.0040.000046%-
Contusion12.01.06.001; 15.03.05.007; 23.03.11.002; 24.07.06.001--
Acute coronary syndrome02.02.02.015; 24.04.04.011---
Eye pruritus06.04.05.006---
Ocular discomfort06.08.03.008---
Periventricular leukomalacia17.13.02.005; 18.04.07.0030.000046%-
Musculoskeletal stiffness15.03.05.0270.000046%-
Musculoskeletal discomfort15.03.04.001---
Injection site swelling08.02.03.017; 12.07.03.0180.000180%-
Type IV hypersensitivity reaction10.01.03.022---
Growth retardation05.03.02.007; 14.03.02.031; 15.03.05.016--
Affect lability19.04.01.001---
Scleral thinning06.09.06.004---
The 12th Page    First    Pre   12 13 14    Next   Last    Total 14 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene